Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Horizon Lines: A Quarterly Review of NDAs – October- December 2025
This quarterly review of New Drug Applications contains data for applications approved for the first time during the last quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 40 applications were approved by the FDA during these three months. read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
Flexibility as a Core IND Strategy
With the increasing complexities of current IND programs, it is critical to work with regulatory agencies to seek input early in the process. read more
Five Steps to Smooth Agentic AI Adoption
In agentic AI-enabled labs, AI goes from individual, one-off applications to comprehensive workflow orchestration. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Circio And Avenue Biosciences Launch Gene Therapy Research Collaboration On Protein Secretion
Thursday, July 16, 2026
Circio Holding ASA and Avenue Biosciences have entered a research collaboration aimed at improving long-term expression and secretion of therapeutic ... read more
GemPharmatech And Humlab Global Sign Distribution Deal For Humanized Mouse Models
Thursday, July 16, 2026
GemPharmatech and Humlab Global have signed a strategic agreement to distribute existing and novel humanized mouse strains worldwide, aiming to ... read more
Crown Bioscience Joins C-Path's NAMs Developer Coalition to Advance Human-Relevant Models in Drug Development
Thursday, July 16, 2026
Crown Bioscience announced it has joined Critical Path Institute's (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC), a collaborative... read more
Insilico Medicine And Bora Pharmaceuticals Announce AI-Driven Drug Discovery And Manufacturing Alliance
Thursday, July 16, 2026
Insilico Medicine and Bora Pharmaceuticals have announced a proposed multi-target strategic alliance that would link Insilico’s artificial ... read more
Valion Bio Highlights Scale-Up And Oncology Plans For Entolimod Biodefense Platform
Tuesday, July 14, 2026
Valion Bio reported a set of strategic developments around its Toll like receptor 5 (TLR5) agonist Entolimod, underscoring plans to build an ... read more

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Latest Articles